eli lilly retatrutide study Today, we shared new data from the latest Phase 3 of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more VisualAbstract: Retatrutide reduces body weight

Common examples include: Ozempic Wegovy Mounjaro Zepbound Their growing popularity has also increased interest in understanding the full range of possible medication side effects

Choose a day of the week and set a reminder for your dose

J., Wu, Q., Lalonde, A., Ahmad, N., & Bethel, M

In SURMOUNT-2, the mean WL was up to 15.7% with tirzepatide 15 mg compared to 3.3% WL with placebo at 72 weeks for people with obesity and T2D [47]

Want to dive deeper into protein strategies

At the same time, this trend raises important questions around: Appropriate use Long-term safety Role of medical supervision It also reflects a larger transformation in how metabolic health is being approached globally